title: Safety of statins.
abstract: Statins are an established class of drugs with proven efficacy in cardiovascular risk reduction. The concern over statin safety was first raised with the revelation of myopathy and rhabdomyolysis with the use of now withdrawn cerivastatin. Enhanced understanding of the mechanisms behind adverse effects of statins including an insight into the pharmacokinetic properties have minimised fear of statin use among clinicians. Studies reveal that occurrence of myopathy and rhabdomyolysis are rare 1/100000 patient-years. The risk of myopathy/rhabdomyolysis varies between statins due to varying pharmacokinetic profiles. This explains the differing abilities of statins to adverse effects and drug interaction potentials that precipitate adverse effects. Higher dose of rosuvastatin (80 mg/day) was associated with proteinuria and hematuria while lower doses were devoid of such effects. Awareness of drugs interacting with statins and knowledge of certain combinations such as statin and fibrates together with monitoring of altered creatine kinase activity may greatly minimise associated adverse effects. Statins also asymptomatically raise levels of hepatic transaminases but are not correlated with hepatotoxicity. Statins are safe and well tolerated including more recent potent statins such as, rosuvastatin. The benefits of intensive statin use in cardiovascular risk reduction greatly outweigh risks. The present review discusses underlying causes of statin-associated adverse effects including management in high risk groups.
authors: Division of Cardiology, Department of Medicine, Vivekanand Institute of Medical Sciences, Kolkata, India.
authors: Debasish
authors: D
authors: Maji
authors: Shehla
authors: S
authors: Shaikh
authors: Dharmesh
authors: D
authors: Solanki
authors: Kumar
authors: K
authors: Gaurav
keywords: Myopathy; rhabdomyolysis; safety of statins; statins
references: N Engl J Med. 2004 Apr 8;350(15):1579-82
references: 15071140
references: Prog Cardiovasc Nurs. 2006 Summer;21(3):140-5
references: 16957460
references: Br J Clin Pharmacol. 2004 Sep;58(3):326-8
references: 15327593
references: Atherosclerosis. 2007 Nov;195(1):7-16
references: 17094994
references: Pharmacotherapy. 2004 Feb;24(2):285-90
references: 14998226
references: Mol Cell Biochem. 2003 Jul;249(1-2):129-40
references: 12956408
references: Circulation. 2002 Dec 17;106(25):3143-421
references: 12485966
references: Am J Cardiol. 2006 Apr 17;97(8A):89C-94C
references: 16581336
references: Atherosclerosis. 2009 Jan;202(1):18-28
references: 18585718
references: J Ocul Pharmacol Ther. 2004 Apr;20(2):179-82
references: 15117574
references: Am J Cardiol. 2006 Apr 17;97(8A):27C-31C
references: 16581325
references: Lancet. 1999 May 22;353(9166):1763-4
references: 10347994
references: N Engl J Med. 2008 Sep 25;359(13):1309-12
references: 18815394
references: Clin Biochem. 2000 Jun;33(4):279-84
references: 10936586
references: Expert Opin Drug Saf. 2011 May;10(3):373-87
references: 21342078
references: Lancet. 2004 Mar 13;363(9412):892-4
references: 15031036
references: Curr Drug Saf. 2009 Sep;4(3):181-7
references: 19534642
references: N Engl J Med. 2005 Apr 7;352(14):1425-35
references: 15755765
references: Med J Aust. 2001 Nov 5;175(9):486-9
references: 11758079
references: Chest. 2008 Oct;134(4):824-830
references: 18689579
references: JAMA. 2005 Nov 16;294(19):2437-45
references: 16287954
references: Medicine (Baltimore). 2005 Nov;84(6):377-385
references: 16267412
references: Circulation. 2006 Dec 19;114(25):2788-97
references: 17159064
references: Ann Pharmacother. 2001 Jul-Aug;35(7-8):908-17
references: 11485144
references: Lancet. 2005 Oct 8;366(9493):1267-78
references: 16214597
references: Heart Fail Monit. 2003;3(3):82-6
references: 12634877
references: Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):182-7
references: 18316955
references: Am J Cardiol. 2008 Apr 17;101(8A):3B-8B
references: 18375239
references: J Am Coll Cardiol. 2010 Mar 16;55(11):1121-6
references: 20223367
references: Circulation. 2007 Feb 6;115(5):576-83
references: 17261662
references: Expert Opin Drug Saf. 2005 May;4(3):389-97
references: 15934847
references: Pharmacotherapy. 2004 May;24(5):584-91
references: 15162892
references: Endothelium. 1997;5(2):107-13
references: 9237044
references: J Pediatr Pharmacol Ther. 2010 Jul;15(3):160-72
references: 22477808
references: Am J Cardiol. 2006 Mar 1;97(5):748-55
references: 16490450
references: Am J Cardiol. 2003 Aug 21;92(4B):23K-29K
references: 12948873
references: Vasc Health Risk Manag. 2008;4(2):341-53
references: 18561510
references: Clin Pharmacol Ther. 2007 May;81(5):679-84
references: 17301736
references: Atherosclerosis. 2012 Apr;221(2):471-7
references: 22304793
references: Circulation. 2004 Jun 15;109(23 Suppl 1):III50-7
references: 15198967
references: Ann Pharmacother. 2002 Feb;36(2):288-95
references: 11847951
references: CMAJ. 2009 Jul 7;181(1-2):E11-8
references: 19581603
references: N Engl J Med. 2007 Dec 6;357(23):2329-37
references: 18057335
references: Cardiol Rev. 2009 Jan-Feb;17(1):44-7
references: 19092370
references: Am J Cardiol. 2006 Apr 17;97(8A):52C-60C
references: 16581329
references: Biochem Pharmacol. 2004 Jun 15;67(12):2175-86
references: 15163549
references: Med Sci Monit. 2001 Nov-Dec;7(6):1381-5
references: 11687759
references: Mayo Clin Proc. 2008 Jun;83(6):687-700
references: 18533086
references: Circ Res. 1998 Sep 7;83(5):490-500
references: 9734471
references: Birth Defects Res B Dev Reprod Toxicol. 2004 Jun;71(3):111-23
references: 15282732
references: Prog Lipid Res. 2005 Jul;44(4):235-58
references: 16019076
references: Clin J Am Soc Nephrol. 2011 Mar;6(3):664-78
references: 21393488
references: Lancet. 2007 Nov 24;370(9601):1781-90
references: 17559928
references: Biochem Soc Trans. 2003 Jun;31(Pt 3):528-31
references: 12773150
references: Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):943-52
references: 18425988
references: Mitochondrion. 2007 Jun;7 Suppl:S122-6
references: 17485248
references: Clin Biochem. 2007 Jun;40(9-10):575-84
references: 17467679
references: BMJ. 2003 Jul 19;327(7407):115-6
references: 12869426
references: Curr Drug Saf. 2009 Sep;4(3):209-28
references: 19534648
references: Circ Res. 2003 Nov 14;93(10):948-56
references: 14563711
references: Am J Cardiol. 2005 Jan 1;95(1):120-2
references: 15619408
references: N Engl J Med. 2004 Apr 8;350(15):1495-504
references: 15007110